O
Oswin Chang
Researcher at McMaster University
Publications - 10
Citations - 612
Oswin Chang is an academic researcher from McMaster University. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 3, co-authored 4 publications receiving 123 citations.
Papers
More filters
Journal ArticleDOI
The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis
Jiawen Deng,Fangwen Zhou,Wenteng Hou,Zachary Silver,Chi Yi Wong,Oswin Chang,Emma Huang,Qi Kang Zuo +7 more
TL;DR: A systematic review and random‐effects meta‐analysis to assess the prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients found no significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools.
Journal ArticleDOI
The prevalence of depressive symptoms, anxiety symptoms and sleep disturbance in higher education students during the COVID-19 pandemic: A systematic review and meta-analysis.
Jiawen Deng,Fangwen Zhou,Wenteng Hou,Zachary Silver,Chi Yi Wong,Oswin Chang,Anastasia Drakos,Qi Kang Zuo,Emma Huang +8 more
TL;DR: In this paper, a systematic search of English and Chinese databases was conducted to assess the prevalence of depressive symptoms, anxiety symptoms and sleep disturbances in higher education students during the COVID-19 pandemic.
Journal ArticleDOI
Prevalence of mental health symptoms in children and adolescents during the COVID‐19 pandemic: A meta‐analysis
Jiawen Deng,Fangwen Zhou,Wenteng Hou,K. Heybati,Simran Lohit,Umaima Abbas,Zachary Silver,Chi Yi Wong,Oswin Chang,Emma Huang,Q. Zuo,Myron Moskalyk,Harikrishnaa Ba Ramaraju,Shayan Heybati +13 more
TL;DR: In this paper , the authors conducted a systematic review and meta-analysis to examine the prevalence of depressive symptoms, anxiety symptoms, and sleep disturbances in children and adolescents during the COVID-19 pandemic.
Journal ArticleDOI
Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
TL;DR: A protocol for a two-part NMA that incorporates all available RCT data to provide the most comprehensive ranking of antidiabetics and antiosteoporotic pharmacotherapies in terms of their ability to decrease fracture incidences, increase bone mineral density (BMD) and improve indications of bone turnover markers (BTMs) in adult patients with T2DM is presented.
Journal ArticleDOI
Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis.
Fangwen Zhou,Jiawen Deng,K. Heybati,Q. Zuo,Saif Hasan Ali,Wenteng Hou,Chi Yi Wong,Harikrishnaa Ba Ramaraju,Oswin Chang,Thanansayan Dhivagaran,Zachary Silver +10 more
TL;DR: Coricosteroids should be considered in patients requiring mechanical ventilation, and glycemic monitoring may be needed when administering corticosteroids.